Miles of Hope Announces IBM Groundbreaking Presentation at Annual Event
The Miles of Hope Breast Cancer Foundation announced today that on May 1, at the Foundation’s annual Spring Brunch in Poughkeepsie, IBM will present groundbreaking innovations for treating breast cancer with Watson Health.
Nicknamed Watson for Oncology, the cloud-based cognitive computing platform developed by IBM, provides personalized, evidence-based treatment recommendations by analyzing a patient’s data, such as genetics, lifestyle and hospital scans.
According to hospital officials in published articles and reports, it takes Watson Health less than a minute to sift through large volumes of patient information, medical research and worldwide medical guidelines and provide a report detailing individualized treatment options.
According to one health care administrator, “in the future, breast cancer won’t be breast cancer. It will be a series of molecular cancers that occur in the breast — same with colorectal cancer. Treatment will be based on the molecular genetics of the cancer rather than the histology of the cancer.”
“Targeted therapies, molecular therapies and chain therapies will come along and keeping track will be increasingly difficult. Watson Health provides us a way to be virtually and instantaneously up-to-date.”
From an article in Wired: “According to Sloan-Kettering, only around 20% of the knowledge that human doctors use when diagnosing patients and deciding on treatments relies on trial-based evidence. It would take at least 160 hours of reading a week just to keep up with new medical knowledge as it’s published, let alone consider its relevance or apply it practically. Watson’s ability to absorb this information faster than any human should, in theory, fix a flaw in the current healthcare model.”
Pari Forood, Executive Director of the Miles of Hope Breast Cancer Foundation said: “In a nutshell, Watson Health gathers patient data and compares these against known cases. It then provides a report detailing options for individualized treatments. This system hopes to fill ‘skill gaps’ across healthcare and other industries thus revolutionizing breast cancer treatment.”
She continued: “We are thrilled that IBM has chosen the Miles of Hope event to present this game-changing innovation to the Hudson Valley, its home for so many years. We fund support services for people affected by breast cancer within the 8 counties of the Hudson Valley but if Watson Health puts us out of business, we are ok with that!”
Major sponsors of the event include: Health Quest, James J. McCann Charitable Trust, Arnoff Moving and Storage, Premier Medical Group, Hudson Cadillac/Buick/GMC, Hudson Valley Federal Credit Union, Hudson River Fruit, Marcia Brady Tucker Foundation, C2G Environmental, Jane W. Nuhn Trust, Dr. Joel Canter, Poughkeepsie South Rotary Club, Millman Harris Romano Foundation, Race for the Cure, Judelson Giordano and Seigel, Berkshire Hathaway, Caremount Medical, D’Arcangelo, Advance Testing, North River Abstract, Monica and Jacob Frydman, The Kapstone Corporation, Williams Lumber and Home Center, Rose and Kiernan, Poughkeepsie Journal, Dutchess Pro Print, Harold Albinder, Brookside Meadowns, NY Design Center, Dana and Ira Effron.
Photo attachment (L-R): Miles of Hope Co-Founder Cathy Varunok, Executive Director Pari Forood, Co-Founder Dana Effron
For more information:
Miles of Hope – 845-264-2005 or